Belite Bio is Drug Discovery in United States that focus on Stargardt disease business. Founded in 2016. They cover business area such as operator, clinical-stage drug development company, untreatable inherit orphan disease, age-relate metabolic disease, atrophic Age-relate Macular Degeneration, ([dq]STGD, juvenile macular degeneration, NASH, Nonalcoholic steatohepatitis, therapy, untreatable neurological disorder, liver disease, diabete, healthcare provider, aid.
2016
( 8 years old in 2024 )
Stargardt Disease
-
3210 Merryfield Row
San Diego, CA 92121
United States
Private
operatorclinical-stage drug development companyuntreatable inherit orphan diseaseage-relate metabolic diseaseatrophic Age-relate Macular Degeneration([dq]STGDjuvenile macular degenerationNASHNonalcoholic steatohepatitistherapyuntreatable neurological disorderliver diseasediabetehealthcare provideraid
* We use standard office opening hours in near Belite Bio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Belite Bio is Drug Discovery business from United States that founded in 2016 (8 years old in 2024), Belite Bio business is focusing on Stargardt Disease.
Belite Bio headquarter office and corporate office address is located in 3210 Merryfield Row San Diego, CA 92121 United States.
Belite Bio was founded in United States.
In 2024, Belite Bio is currently focus on Stargardt disease sector.
Above is snippet of Google Trends for "Stargardt disease" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Belite Bio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
